{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:24:32Z","timestamp":1794439472097,"version":"4.9.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100030692","name":"National Institute on Drug Abuse Intramural Research Program","doi-asserted-by":"publisher","award":["1K01DA052821"],"award-info":[{"award-number":["1K01DA052821"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"National Institute on Drug Abuse Intramural Research Program","doi-asserted-by":"publisher","award":["T32DA041898"],"award-info":[{"award-number":["T32DA041898"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30DA040500"],"award-info":[{"award-number":["P30DA040500"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018578","name":"Boston University Clinical & Translational Science Institute","doi-asserted-by":"publisher","award":["1UL1TR001430"],"award-info":[{"award-number":["1UL1TR001430"]}],"id":[{"id":"10.13039\/100018578","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["1K01MH127253"],"award-info":[{"award-number":["1K01MH127253"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["P30AI042853"],"award-info":[{"award-number":["P30AI042853"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008601","name":"Charles A King Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.amepre.2026.108392","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T01:02:02Z","timestamp":1780016522000},"page":"108392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of Continuous Medicaid Eligibility With Postpartum Coverage and Opioid Use Disorder Treatment"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5203-9455","authenticated-orcid":false,"given":"Breanne E.","family":"Biondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0654-5821","authenticated-orcid":false,"given":"Paul R.","family":"Shafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2831-8865","authenticated-orcid":false,"given":"Rachel L.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6380-8523","authenticated-orcid":false,"given":"Jamie R.","family":"Daw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4743-2014","authenticated-orcid":false,"given":"Sarah H.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.amepre.2026.108392_bib0001","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00737-023-01334-z","article-title":"Time to pay attention: an underrecognized casualty of the opioid epidemic","volume":"26","author":"White","year":"2023","journal-title":"Arch Womens Ment Health"},{"issue":"3","key":"10.1016\/j.amepre.2026.108392_bib0002","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/jamapsychiatry.2023.4523","article-title":"Pregnancy and postpartum drug overdose deaths in the U.S. before and during the COVID-19 pandemic","volume":"81","author":"Han","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.amepre.2026.108392_bib0003","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","article-title":"Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts","volume":"132","author":"Schiff","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.amepre.2026.108392_bib0004","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2105\/AJPH.2018.304771","article-title":"Amphetamine- and opioid-affected births: incidence, outcomes, and costs, United States, 2004\u20132015","volume":"109","author":"Admon","year":"2019","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.amepre.2026.108392_bib0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/AOG.0000000000005115","article-title":"Postpartum opioid-related mortality in patients with public insurance","volume":"141","author":"Suarez","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.amepre.2026.108392_bib0006","series-title":"Opioid use and opioid use disorder in pregnancy: Committee Opinion No. 711","year":"2017"},{"issue":"11","key":"10.1016\/j.amepre.2026.108392_bib0007","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamapediatrics.2023.3072","article-title":"Medications for opioid use disorder during the prenatal period and infant outcomes","volume":"177","author":"Ali","year":"2023","journal-title":"JAMA Pediatr"},{"issue":"12","key":"10.1016\/j.amepre.2026.108392_bib0008","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1111\/add.15959","article-title":"Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study","volume":"117","author":"Burns","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.amepre.2026.108392_bib0009","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.drugpo.2019.06.019","article-title":"They\u2019re making it so hard for people to get help\u201d: motivations for non-prescribed buprenorphine use in a time of treatment expansion","volume":"71","author":"McLean","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"2","key":"10.1016\/j.amepre.2026.108392_bib0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jmwh.13165","article-title":"The lived experience of postpartum women attending outpatient substance treatment for opioid or heroin use","volume":"66","author":"Proulx","year":"2021","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.amepre.2026.108392_bib0011","author":"Yarmuth"},{"key":"10.1016\/j.amepre.2026.108392_bib0012","series-title":"Medicaid postpartum coverage extension tracker","year":"2026"},{"key":"10.1016\/j.amepre.2026.108392_bib0013","unstructured":"Lowey NM. Text - H.R.6201 - 116th Congress (2019-2020) 2020. Families First Coronavirus Response Act. https:\/\/www.congress.gov\/bill\/116th-congress\/house-bill\/6201. Accessed November 29, 2022."},{"key":"10.1016\/j.amepre.2026.108392_bib0014","unstructured":"H.R.2617 - Consolidated Appropriations Act, 2023: 117th Congress (2021-2022). Congress.Gov. https:\/\/www.congress.gov\/bill\/117th-congress\/house-bill\/2617\/text. Updated December 29, 2022. Accessed May 14, 2024."},{"issue":"3","key":"10.1016\/j.amepre.2026.108392_bib0015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1377\/hlthaff.2023.00580","article-title":"COVID-19 Medicaid continuous enrollment provision yielded gains in postpartum continuity of coverage","volume":"43","author":"Gordon","year":"2024","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"10.1016\/j.amepre.2026.108392_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2021.1054","article-title":"Factors associated with postpartum uninsurance among Medicaid-paid births","volume":"2","author":"Daw","year":"2021","journal-title":"JAMA Health Forum"},{"issue":"4","key":"10.1016\/j.amepre.2026.108392_bib0017","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.0688","article-title":"Changes in postpartum insurance coverage in the U.S. during the COVID-19 pandemic","volume":"3","author":"Eliason","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"6","key":"10.1016\/j.amepre.2026.108392_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2025.1630","article-title":"Postpartum Medicaid use in birthing parents and access to financed care","volume":"6","author":"Swartz","year":"2025","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.amepre.2026.108392_bib0019","unstructured":"TriNetX - the World\u2019s largest, living ecosystem of real-world data and evidence. TriNetX. https:\/\/trinetx.com\/. Updated 5\/12\/2026. Accessed January 30, 2023."},{"key":"10.1016\/j.amepre.2026.108392_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108677","article-title":"Conceptualizing stigma in contexts of pregnancy and opioid misuse: a qualitative study with women and healthcare providers in Ohio","volume":"222","author":"Syvertsen","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.amepre.2026.108392_bib0021","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/AOG.0000000000001446","article-title":"Opioid use disorder in pregnancy: health policy and practice in the midst of an epidemic","volume":"128","author":"Krans","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.amepre.2026.108392_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002963","article-title":"Defining a recovery-oriented cascade of care for opioid use disorder: a community-driven, statewide cross-sectional assessment","volume":"16","author":"Yedinak","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.amepre.2026.108392_bib0023","series-title":"Treatment of Opioid Use Disorder","author":"Lu","year":"2024"},{"issue":"22","key":"10.1016\/j.amepre.2026.108392_bib0024","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1001\/jama.2014.16153","article-title":"Methods for evaluating changes in health care policy: the difference-in-differences approach","volume":"312","author":"Dimick","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amepre.2026.108392_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1257\/jep.31.2.3","article-title":"The state of applied econometrics: causality and policy evaluation","volume":"31","author":"Athey","year":"2017","journal-title":"J Econ Perspect"},{"issue":"4","key":"10.1016\/j.amepre.2026.108392_bib0026","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1176\/appi.ps.202100191","article-title":"Telehealth adoption by mental health and substance use disorder treatment facilities in the COVID-19 pandemic","volume":"73","author":"Cantor","year":"2022","journal-title":"Psychiatr Serv"},{"issue":"3","key":"10.1016\/j.amepre.2026.108392_bib0027","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.0004","article-title":"Continuous Medicaid eligibility during the COVID-19 pandemic and postpartum coverage, health care, and outcomes","volume":"5","author":"Daw","year":"2024","journal-title":"JAMA Health Forum"},{"issue":"3","key":"10.1016\/j.amepre.2026.108392_bib0028","doi-asserted-by":"crossref","DOI":"10.1111\/1475-6773.14395","article-title":"Effects of the continuous Medicaid coverage provision of the family first coronavirus response act on postpartum Medicaid coverage, depression symptoms, and birth control use","volume":"60","author":"Ejughemre","year":"2024","journal-title":"Health Serv Res"},{"key":"10.1016\/j.amepre.2026.108392_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109715","article-title":"Non-engagement in substance use treatment among women with an unmet need for treatment: a latent class analysis on multidimensional barriers","volume":"242","author":"Apsley","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.amepre.2026.108392_bib0030","series-title":"Medications for Opioid Use Disorder Save Lives","author":"Leshner","year":"2019"},{"key":"10.1016\/j.amepre.2026.108392_bib0031","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.amepre.2026.108392_bib0032","article-title":"Impact of COVID-19 on MOUD retention in a sample of rural primary care patients: a secondary analysis of electronic health records","volume":"12","author":"Calhoun","year":"2024","journal-title":"Drug Alcohol Depend Rep"},{"issue":"5","key":"10.1016\/j.amepre.2026.108392_bib0033","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/ajad.13417","article-title":"Opioid use disorder at delivery hospitalization in the United States: 2012\u20132016","volume":"32","author":"Malhotra","year":"2023","journal-title":"Am J Addict"},{"issue":"2","key":"10.1016\/j.amepre.2026.108392_bib0034","first-page":"1","article-title":"Births: final data for 2019","volume":"70","author":"Martin","year":"2021","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.amepre.2026.108392_bib0035","doi-asserted-by":"crossref","unstructured":"Smith SM, Edwards R, Duong HC. Unemployment rises in 2020, as the country battles the COVID-19 pandemic : monthly labor review. Washington, DC: U.S. Bureau of Labor Statistics. U.S. Bureau of Labor Statistics. https:\/\/doi.org\/10.21916\/mlr.2021.12. Published 2021.","DOI":"10.21916\/mlr.2021.12"},{"key":"10.1016\/j.amepre.2026.108392_bib0036","unstructured":"SAMHSA Opioid treatment program (OTP) guidance. 2020. https:\/\/www.samhsa.gov\/substance-use\/treatment\/opioid-treatment-program\/methadone-guidance. Accessed November 29, 2022."},{"key":"10.1016\/j.amepre.2026.108392_bib0037","series-title":"Telehealth and substance use disorder services in the era of COVID-19: review and recommendations","year":"2022"},{"issue":"23","key":"10.1016\/j.amepre.2026.108392_bib0038","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2020.22154","article-title":"Changes in outpatient buprenorphine dispensing during the COVID-19 pandemic","volume":"324","author":"Cance","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.amepre.2026.108392_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108641","article-title":"A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic","volume":"135","author":"Cunningham","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.amepre.2026.108392_bib0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jama.2023.9043","article-title":"Trends in state-Level Maternal Mortality by Racial and Ethnic Group in The United States","volume":"330","author":"Fleszar","year":"2023","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.amepre.2026.108392_bib0041","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1001\/jama.2022.17045","article-title":"U.S. trends in drug overdose mortality among pregnant and postpartum persons, 2017\u20132020","volume":"328","author":"Bruzelius","year":"2022","journal-title":"JAMA"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379726001352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379726001352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:02:37Z","timestamp":1794438157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379726001352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0749379726001352"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2026.108392","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Continuous Medicaid Eligibility With Postpartum Coverage and Opioid Use Disorder Treatment","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2026.108392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108392"}}